Stroke Journal

OCTOBER 31, 2024

Stroke, Ahead of Print. Ischemic stroke is one of the leading causes of disability and mortality worldwide. Thrombosis is the main pathological process of stroke and is therefore an important therapeutic target in stroke prevention.

Stroke 40

Stroke Strokes Thrombosis Plaque 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP268-ATP268, February 1, 2025. Introduction:Xylitol, a sugar alcohol with a global market estimated at 161,500 metric tons, has been linked to increased thrombosis and risk of stroke and heart attack. The mean BMI was 35.2 kg/m2, HbA1c was 5.9% 0.4,

Thrombosis 40

Thrombosis Obesity Stroke Strokes 40

European Journal of Heart Failure

OCTOBER 31, 2023

The comorbidity of HF and stroke is a high risk condition that requires particular attention to ensure early detection of complications, efficient diagnostic workup, close monitoring, and consequent treatment of the patient. Beside the physicians perspective, also the patients values and preferences are taken into account.

Heart Failure 40

Heart Failure Thrombosis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A151-A151, February 1, 2025. Introduction:Stroke is a leading cause of maternal morbidity and mortality, and the incidence of maternal stroke is triple that of age-matched, non-pregnant counterparts. Characteristics of the study population are shown in the Table.

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP227-AWP227, February 1, 2024. Introduction:Deep medullary vein(DMV) thrombosis is a rare cause of neurological damage noted in both term and preterm infants. The spectrum of parenchymal radiological findings in DMV thrombosis includes edema and hemorrhage of variable extent.

Thrombosis 40

Thrombosis Hemorrhage Stroke Strokes 40

Stroke Journal

JANUARY 21, 2024

Stroke, Volume 55, Issue 2 , Page 311-323, February 1, 2024. Intracranial atherosclerotic disease (ICAD) is one of the most common causes of stroke worldwide. In addition to stroke, ICAD increases the risk of dementia and cognitive decline, magnifying ICAD societal burden.

Stenosis 74

Stenosis Thrombosis Dementia Embolism 74

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP96-ATMP96, February 1, 2025. Introduction:Pediatric arterial ischemic stroke (AIS) affects 1-2 per 100,000 children. Patients treated for concomitant venous thrombosis and/or without follow up imaging were excluded. Data was de-identified and SAS 8.3 was used for analysis.

Pediatrics 40

Pediatrics Stroke Strokes Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP355-AWP355, February 1, 2025. Stroke outcomes were assessed at 24 hours.Results:Exposure to long wavelength red light resulted in a significant reduction in infarct volume following stroke (mice-red 38.817.6 The change in thrombosis only occurred when mice were pre-exposed to red light.

Stroke 40

Stroke Strokes Thrombosis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP16-ATMP16, February 1, 2025. Elevated levels of Lp(a) are an independent and causal risk factor for atherosclerotic cardiovascular diseases through mechanisms associated with increased atherogenesis, inflammation, and thrombosis.

Stroke 40

Stroke Strokes Academic Hospital 40

Circulation

NOVEMBER 11, 2024

Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). Patients with hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) have a higher incidence of strokes and transient ischemic attacks.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP117-ATMP117, February 1, 2025. Introduction:Despite timely recanalization, some ischemic stroke patients treated with endovascular thrombectomy experience persistent neurological deterioration. Experimental stroke models have indicated a critical role for platelets in this process.

Stroke 40

Stroke Strokes Thrombosis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP67-ATP67, February 1, 2025. Introduction:Ongoing staff stroke education is crucial to ensure that stroke knowledge remains current and at the forefront of everyone's minds and is also required for stroke certification.

Education 40

Education Stroke Strokes Certification 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP134-AWP134, February 1, 2025. Introduction:Stroke is a leading cause of maternal morbidity and mortality, and hemorrhagic strokes account for up to half of these cases. Prior studies in non-maternal populations demonstrated that 9% of strokes are missed at initial ED presentation.

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

OCTOBER 1, 2024

Stroke, Ahead of Print.

Thrombosis 40

Thrombosis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2025. Background:The mechanisms by which intracranial atherosclerosis (ICAS) contributes to large-vessel occlusion strokes (LVOS) remains unclear. Among patients with lower fibrinogen levels (< 3.2g/L),

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP117-ATMP117, February 1, 2024. Stroke is a serious complication of diabetes. Earlier, we demonstrated that exposure to single hypoglycemia (SH), 5-day RH (once every day), and twice-a-week RH for 6 weeks increases stroke risk in male insulin-treated diabetic (ITD) rats.

Diabetes 40

Diabetes Stroke Strokes Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2025. Background and Purpose:External counterpulsation (ECP) is a novel noninvasive method used to improve the perfusion of vital organs, which may benefit ischemic stroke patients. of 65 patients in ECP group compared to 9.1%

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

JANUARY 26, 2025

Stroke, Volume 56, Issue 2 , Page 527-532, February 1, 2025. BACKGROUND:Acute ischemic stroke treatment typically involves tissue-type plasminogen activator (tPA) or tenecteplase, but about 50% of patients do not achieve successful reperfusion. DNase-I, which degrades neutrophil extracellular traps, could improve thrombolytic efficacy.

Hemorrhage 40

Hemorrhage Stroke Strokes Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionPediatric patients presenting with atypical stroke symptoms pose a diagnostic challenge, which often causes delays in management. Around a quarter of pediatric stroke patients will present with new onset seizures.

Pediatrics 40

Pediatrics Stroke Strokes Quality of Life 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP366-ATP366, February 1, 2025.

Stroke 40

Stroke Strokes Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP259-AWP259, February 1, 2024. Cases had a maternal stroke (ischemic, hemorrhagic, subarachnoid hemorrhage, or cerebral venous thrombosis) during pregnancy or PP, identified from a stroke registry. Population characteristics are shown in the Table. 95% confidence interval 3.8-48.5,

Hypertension 40

Hypertension Stroke Strokes Blood Pressure 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%.

COVID-19 40

COVID-19 Thrombosis Outcomes Hospital 40

Frontiers in Cardiovascular Medicine

JULY 22, 2024

These included three cases of intraoperative thrombosis, three instances of pericardial effusion or tamponade, one case of device-related thrombosis, one peri-device leak, one systemic embolism, one bleeding episode, and one additional device-related complication.

Ablation 59

Ablation Thrombosis Embolism Atrial Fibrillation 59

Stroke Journal

JANUARY 30, 2025

Stroke, Ahead of Print.

Thrombosis 40

Thrombosis Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2024. Background:Information on long-term care utilization patterns following the acute care period of cerebral venous thrombosis (CVT) is limited. The most common neurologic reasons for readmission differed by age group, but included headaches, seizures, and stroke.

Thrombosis 40

Thrombosis Cancer Stroke Strokes 40

DAIC

MARCH 31, 2025

These results suggest that abelacimab may be safe across the spectrum of bleeding risk and may make it possible to anticoagulate some of the most vulnerable populations who otherwise would not be treated and therefore left unprotected from the risk of stroke. Data from these trials are expected in the second half of 2026.

Atrial Fibrillation 52

Atrial Fibrillation BMI General Cardiology Thrombosis 52

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A19-A19, February 1, 2024. Background:Preceding respiratory tract infections (RTI) due to bacteria or virus has been linked to an increasing risk of stroke likely by potentiating an inflammatory immune response, endothelial dysfunction, platelet activation, and coagulopathy. In contrast,S.

Outcomes 40

Outcomes Stroke Strokes Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP154-AWP154, February 1, 2024. Prolonged ICU stay were more likely to have higher baseline median NIHSS score (19 vs. 14%, p < 0.0001), posterior circulation stroke (12.6% vs. 6.1%, p = 0.0002), deep vein thrombosis (7.3 vs. 6.1%, p = 0.0002), deep vein thrombosis (7.3

ICU 40

ICU Thrombolysis Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A139-A139, February 1, 2024. Background:A current national priority is to understand geographic disparities in mechanical thrombectomy (MT) provision for patients with acute ischemic stroke (AIS).

Stroke 40

Stroke Strokes Inpatient Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. It can occasionally present primarily with neurological conditions such as ischemic strokes, encephalopathy, or sensory neuropathy. His initial National Institutes of Health Stroke Scale was 3 for bilateral leg weakness.

Stroke 40

Stroke Strokes Laboratory Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP62-ATMP62, February 1, 2024. Introduction:Seizures are a common initial manifestation of cerebral venous thrombosis (CVT). The primary outcome was delayed seizure(s), occurring after 7 days from CVT diagnosis. Univariate analysis was performed using Chi-square, rank-sum, and t-tests.

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCerebral sinus venous thrombosis (CSVT) has traditionally been treated medically with systemic anticoagulation. Recent advances in endovascular therapy (EVT) may represent an alternative treatment to medical therapy for CSVT.

Thrombosis 40

Thrombosis Outcomes Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP278-ATP278, February 1, 2024. The "PAIST Scale" of the thrombolysis patients included: Baseline NIHSS (5-15 = 11, ≥ 16 = 20), deep vein thrombosis (yes = 5), Neuron specific enolase (> 13 ng/ml = 3), and neutrophil percentage (> 70% = 5). mmol/l = 2), serum potassium (< 3.8

Thrombolysis 40

Thrombolysis Thrombosis Stroke Strokes 40

Stroke Journal

OCTOBER 5, 2023

Stroke, Volume 54, Issue 12 , Page e494-e495, December 1, 2023.

Thrombosis 40

Thrombosis Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP7-ATP7, February 1, 2024. Our findings highlight the potential of conservative care for ruptured spinal artery aneurysms, with spontaneous thrombosis demonstrated on short-term follow-up angiograms. While morbidity and mortality seem low, limited data makes generalizations difficult.

Aneurysm 40

Aneurysm Thrombosis Hypertension Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP149-AWP149, February 1, 2024. Background:Direct oral anticoagulants (DOACs) are suitable for some patients with cerebral venous thrombosis (CVT). The optimal transition strategy from parenteral anticoagulation (PA) to DOAC is not known.

Thrombosis 40

Thrombosis Outcomes Hemorrhage Stroke 40

HeartRhythm

APRIL 30, 2024

Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF). Novel oral anticoagulants (NOACs) effectively reduce the prevalence of LAA thrombosis and stroke risk.

Atrial Fibrillation 40

Atrial Fibrillation Thrombosis Embolism Stroke 40